STOCK TITAN

Sangamo Therapeutics Announces First Quarter 2022 Conference Call and Webcast

Rhea-AI Impact
(Neutral)
Rhea-AI Sentiment
(Neutral)
Tags
Rhea-AI Summary

Sangamo Therapeutics (NASDAQ: SGMO) announced the release of its first quarter 2022 financial results, scheduled for May 5, 2022, after market close. A conference call will be held at 4:30 p.m. ET to discuss the results and provide business updates, accessible via telephone and webcast. Domestic callers can dial (877) 377-7553, while international participants may call (678) 894-3968, using conference ID 3090098. A replay will be available for one week following the event. For more information, visit the Sangamo Therapeutics website.

Positive
  • None.
Negative
  • None.

BRISBANE, Calif.--(BUSINESS WIRE)-- Sangamo Therapeutics, Inc. (Nasdaq: SGMO), a genomic medicine company, announced today that the company has scheduled the release of its first quarter 2022 financial results after the market closes on Thursday May 5, 2022. The press release will be followed by a conference call at 4:30 p.m. ET, which will be open to the public via telephone and webcast. During the conference call, the company will review its financial results and provide business updates.

The conference call dial-in numbers are (877) 377-7553 for domestic callers and (678) 894-3968 for international callers. The conference ID number for the call is 3090098. Participants may access the live webcast via a link on the Sangamo Therapeutics website in the Investors and Media section under Events and Presentations. A replay will be available for one week following the conference call via the replay numbers for domestic and international callers: (855) 859-2056 and (404) 537-3406, respectively. The conference ID number for the replay is 3090098.

About Sangamo Therapeutics

Sangamo Therapeutics is committed to translating ground-breaking science into genomic medicines with the potential to transform patients’ lives using gene therapy, cell therapy, and genome engineering. For more information about Sangamo, visit www.sangamo.com.

Investor & Media Inquiries

Louise Wilkie

ir@sangamo.com

media@sangamo.com

Source: Sangamo Therapeutics, Inc.

FAQ

When will Sangamo Therapeutics release its Q1 2022 financial results?

Sangamo Therapeutics will release its Q1 2022 financial results on May 5, 2022, after market close.

What time is the conference call for Sangamo Therapeutics Q1 2022 results?

The conference call for Sangamo Therapeutics Q1 2022 results is scheduled for 4:30 p.m. ET.

How can I access the Sangamo Therapeutics Q1 2022 financial results conference call?

The call can be accessed via telephone at (877) 377-7553 for domestic callers and (678) 894-3968 for international callers.

Is there a replay available for the Sangamo Therapeutics Q1 2022 conference call?

Yes, a replay of the conference call will be available for one week following the event.

Sangamo Therapeutics, Inc.

NASDAQ:SGMO

SGMO Rankings

SGMO Latest News

SGMO Stock Data

507.01M
202.90M
2.36%
27.06%
6.42%
Biotechnology
Biological Products, (no Disgnostic Substances)
Link
United States of America
RICHMOND